For the quarter ending 2025-09-30, OGEN made $3,191,915 in revenue. -$3,066,589 in net income. Net profit margin of -96.07%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Research and development | 930,894 | 449,679 | 879,041 | 906,779 |
| General and administrative | 2,192,879 | 1,264,523 | 1,558,239 | 1,399,221 |
| Total operating expenses | 3,123,773 | 1,714,202 | 2,437,280 | 2,306,000 |
| Loss from operations | -3,123,773 | -1,714,202 | -2,437,280 | -2,306,000 |
| Interest income | 68,142 | 16,793 | 9,466 | 6,405 |
| Interest expense | 7,039 | 572,310 | 9,971 | 1,803 |
| Foreign currency exchange net | -3,919 | -2,316 | -25,085 | -3,692 |
| Total other income (expense), net | 57,184 | -557,833 | -25,590 | 910 |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | - | -2,462,870 | -2,305,090 |
| Net loss | -3,066,589 | -2,272,035 | -2,462,870 | -2,305,090 |
| Basic net loss per share | -1.96 | -3.1 | -0.38 | -0.51 |
| Diluted net loss per share | -1.96 | -3.1 | -0.38 | -0.51 |
| Weight-average shares outstanding, basic | 1,560,909 | 731,817 | 6,528,064 | 4,529,045 |
| Weight-average shares outstanding, diluted | 1,560,909 | 731,817 | 6,528,064 | 4,529,045 |
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)